Last reviewed · How we verify
NCT04813549
Evaluation of Fibromyalgia Syndrome and Its Effect on Quality of Life in Rheumatoid Arthritis
trial in Rheumatoid Arthritis in 85 participants. Completed in 30 November 2022.
30 September 2022
Quick facts
| Lead sponsor | Ahi Evran University Education and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 85 |
| Start date | 1 April 2021 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 November 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Fibromyalgia — all drugs for Fibromyalgia →
- Fibromyalgia, Secondary — all drugs for Fibromyalgia, Secondary →
Sponsor
Ahi Evran University Education and Research Hospital
Who can join
Adults 18 to 65, any sex, with Rheumatoid Arthritis or Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rheumatoid arthritis is a chronic, autoimmune, systemic inflammatory disease with a prevalence of approximately 1%. With a lifetime development rate of 3.6%, rheumatoid arthritis is seen 1.7% more in women than in men. Although there are no diagnostic criteria for rheumatoid arthritis, ACR / EULAR 2010 classification criteria are frequently used in diagnosis. Symptom duration, number of swollen joints, acute phase reactants and serology are used in these criteria. Fibromyalgia syndrome is characterized by chronic widespread pain, fatigue, exercise disorders and cognitive impairment. Although the prevalence of fibromyalgia syndrome in the general population is between 2-4%, it is one of the most common conditions encountered by rheumatologists. A treat to target strategy is recommended in rheumatoid arthritis disease management. This approach suggests close monitoring of disease activity and treatment change in cases where the goal is not achieved. The prevalence of fibromyalgia in rheumatoid arthritis patients was found to be 5-52% in meta-analyzes due to the heterogeneity of fibromyalgia criteria used in studies. This study, it was aimed to evaluate the effect of secondary fibromyalgia syndrome, which is frequently found in rheumatoid arthritis and characterized by symptoms such as fatigue and widespread pain, on rheumatoid arthritis disease activation and patients' quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04813549
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Ahi Evran University Education and Research Hospital trials
Trials by the same sponsor.
- NCT07377292 — Effectiveness of Core Stabilization Exercises in Rotator Cuff Injuries · NA · recruiting
- NCT07510503 — THE USE OF TWO DIFFERENT SMARTPHONE APPLICATIONS IN MEASURING SAGITTAL SPINAL CURVATURE · not yet recruiting
- NCT07320573 — Evaluation of Pelvic Floor Muscle Strength in Women With Stress Urinary Incontinence · not yet recruiting
- NCT07165106 — Effects of Resistance and Aerobic Exercises on Walking and Sarcopenic Parameters in Parkinson's Disease · NA · completed
- NCT06903936 — Comparison of the Effect of Genicular Nerve Block and Physical Therapy in Patients With Knee Osteoarthritis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04813549 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ahi Evran University Education and Research Hospital
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04813549.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing